Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment

Up to 25% of patients recovering from antibiotic-treated Clostridioides difficile infection (CDI) develop functional symptoms reminiscent of Post-Infectious Irritable Bowel Syndrome (PI-IBS). For patients with persistent symptoms following infection, a clinical dilemma arises as to whether to provid...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Digestive and liver disease 2024-11, Vol.56 (11), p.1805-1809
Hauptverfasser:	Taghaddos, Dana, Saqib, Zarwa, Bai, Xiaopeng, Bercik, Premysl, Collins, Stephen M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - therapeutic use Clostridioides difficile Clostridium Infections - complications Clostridium Infections - drug therapy Clostridium Infections - microbiology Clostridium Infections - therapy Dysbiosis Dysbiosis - microbiology Fecal microbial transplant Fecal Microbiota Transplantation Gastrointestinal Microbiome Humans Irritable Bowel Syndrome - microbiology Irritable Bowel Syndrome - therapy Irrritable bowel syndrome Microbiota
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!